Warning: The NCBI web site requires JavaScript to function. more...
Plasmodium vivax dhfr and dhps mutations in isolates from Madagascar and therapeutic response to sulphadoxine-pyrimethamine.
Barnadas C, Tichit M, Bouchier C, Ratsimbasoa A, Randrianasolo L, Raherinjafy R, Jahevitra M, Picot S, Ménard D.
Malar J. 2008 Feb 26;7:35.
Related citations
Molecular surveillance of Plasmodium vivax dhfr and dhps mutations in isolates from Afghanistan.
Zakeri S, Afsharpad M, Ghasemi F, Raeisi A, Safi N, Butt W, Atta H, Djadid ND.
Malar J. 2010 Mar 14;9:75.
Island-wide diversity in single nucleotide polymorphisms of the Plasmodium vivax dihydrofolate reductase and dihydropteroate synthetase genes in Sri Lanka.
Schousboe ML, Rajakaruna RS, Salanti A, Hapuarachchi HC, Galappaththy GN, Bygbjerg IC, Amerasinghe PH, Konradsen F, Alifrangis M.
Malar J. 2007 Mar 9;6:28.
Molecular characterization of antifolates resistance-associated genes, (dhfr and dhps) in Plasmodium vivax isolates from the Middle East.
Zakeri S, Motmaen SR, Afsharpad M, Djadid ND.
Malar J. 2009 Jan 28;8:20.
High prevalence and fixation of Plasmodium vivax dhfr/dhps mutations related to sulfadoxine/pyrimethamine resistance in French Guiana.
Barnadas C, Musset L, Legrand E, Tichit M, Briolant S, Fusai T, Rogier C, Bouchier C, Picot S, Ménard D.
Am J Trop Med Hyg. 2009 Jul;81(1):19-22.
Plasmodium vivax: prevalence of mutations associated with sulfadoxine-pyrimethamine resistance in Plasmodium vivax clinical isolates from Pakistan.
Zakeri S, Afsharpad M, Ghasemi F, Raeisi A, Kakar Q, Atta H, Djadid ND.
Exp Parasitol. 2011 Jan;127(1):167-72. Epub 2010 Jul 23.
Limited polymorphism in the dihydropteroate synthetase gene (dhps) of Plasmodium vivax isolates from Thailand.
Imwong M, Pukrittayakamee S, Cheng Q, Moore C, Looareesuwan S, Snounou G, White NJ, Day NP.
Antimicrob Agents Chemother. 2005 Oct;49(10):4393-5.
Change in mutation patterns of Plasmodium vivax dihydrofolate reductase (Pvdhfr) and dihydropteroate synthase (Pvdhps) in P. vivax isolates from malaria endemic areas of Thailand.
Kuesap J, Rungsrihirunrat K, Thongdee P, Ruangweerayut R, Na-Bangchang K.
Mem Inst Oswaldo Cruz. 2011 Aug;106 Suppl 1:130-3.
Molecular markers of in vivo Plasmodium vivax resistance to amodiaquine plus sulfadoxine-pyrimethamine: mutations in pvdhfr and pvmdr1.
Marfurt J, de Monbrison F, Brega S, Barbollat L, Müller I, Sie A, Goroti M, Reeder JC, Beck HP, Picot S, Genton B.
J Infect Dis. 2008 Aug 1;198(3):409-17.
Plasmodium vivax resistance to chloroquine in Madagascar: clinical efficacy and polymorphisms in pvmdr1 and pvcrt-o genes.
Barnadas C, Ratsimbasoa A, Tichit M, Bouchier C, Jahevitra M, Picot S, Ménard D.
Antimicrob Agents Chemother. 2008 Dec;52(12):4233-40. Epub 2008 Sep 22.
Plasmodium vivax in the Democratic Republic of East Timor: Parasite prevalence and antifolate resistance-associated mutations.
de Almeida A, Rosário VE, Henriques G, Arez AP, Cravo P.
Acta Trop. 2010 Sep;115(3):288-92. Epub 2010 Apr 20.
Different allele prevalence in the dihydrofolate reductase and dihydropteroate synthase genes in Plasmodium vivax populations from China.
Miao M, Yang Z, Cui L, Ahlum J, Huang Y, Cui L.
Am J Trop Med Hyg. 2010 Dec;83(6):1206-11.
Amino acid mutations in Plasmodium vivax DHFR and DHPS from several geographical regions and susceptibility to antifolate drugs.
Auliff A, Wilson DW, Russell B, Gao Q, Chen N, Anh le N, Maguire J, Bell D, O'Neil MT, Cheng Q.
Am J Trop Med Hyg. 2006 Oct;75(4):617-21.
Therapeutic efficacies of artesunate-sulfadoxine-pyrimethamine and chloroquine-sulfadoxine-pyrimethamine in vivax malaria pilot studies: relationship to Plasmodium vivax dhfr mutations.
Tjitra E, Baker J, Suprianto S, Cheng Q, Anstey NM.
Antimicrob Agents Chemother. 2002 Dec;46(12):3947-53.
Association of genetic mutations in Plasmodium vivax dhfr with resistance to sulfadoxine-pyrimethamine: geographical and clinical correlates.
Imwong M, Pukrittakayamee S, Looareesuwan S, Pasvol G, Poirreiz J, White NJ, Snounou G.
Antimicrob Agents Chemother. 2001 Nov;45(11):3122-7.
Geographical distribution of amino acid mutations in Plasmodium vivax DHFR and DHPS from malaria endemic areas of Thailand.
Rungsihirunrat K, Sibley CH, Mungthin M, Na-Bangchang K.
Am J Trop Med Hyg. 2008 Mar;78(3):462-7.
High prevalence of quintuple mutant dhps/dhfr genes in Plasmodium falciparum infections seven years after introduction of sulfadoxine and pyrimethamine as first line treatment in Malawi.
Bwijo B, Kaneko A, Takechi M, Zungu IL, Moriyama Y, Lum JK, Tsukahara T, Mita T, Takahashi N, Bergqvist Y, Björkman A, Kobayakawa T.
Acta Trop. 2003 Mar;85(3):363-73.
Detection of high levels of mutations involved in anti-malarial drug resistance in Plasmodium falciparum and Plasmodium vivax at a rural hospital in southern Ethiopia.
Mula P, Fernández-Martínez A, de Lucio A, Ramos JM, Reyes F, González V, Benito A, Berzosa P.
Malar J. 2011 Aug 2;10:214.
Multiple origins of resistance-conferring mutations in Plasmodium vivax dihydrofolate reductase.
Hawkins VN, Auliff A, Prajapati SK, Rungsihirunrat K, Hapuarachchi HC, Maestre A, O'Neil MT, Cheng Q, Joshi H, Na-Bangchang K, Sibley CH.
Malar J. 2008 Apr 28;7:72.
Drug resistance to sulphadoxine-pyrimethamine in Plasmodium falciparum malaria in Mlimba, Tanzania.
Mbugi EV, Mutayoba BM, Malisa AL, Balthazary ST, Nyambo TB, Mshinda H.
Malar J. 2006 Oct 31;5:94.
Filter your results:
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on